The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 182, 2680 -2689
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0803257

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Archambaud, C.
Right arrow Articles by Malissen, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Archambaud, C.
Right arrow Articles by Malissen, M.

STAT6 Deletion Converts the Th2 Inflammatory Pathology Afflicting LatY136F Mice into a Lymphoproliferative Disorder Involving Th1 and CD8 Effector T Cells1

Cristel Archambaud*,{dagger},{ddagger}, Amandine Sansoni*,{dagger},{ddagger}, Michael Mingueneau*,{dagger},{ddagger}, Elisabeth Devilard*,{dagger},{ddagger}, Georges Delsol§,||, Bernard Malissen2,*,{dagger},{ddagger} and Marie Malissen*,{dagger},{ddagger}

* Centre d’Immunologie de Marseille-Luminy, Université de la Méditerranée, {dagger} Institut National de la Santé et de la Recherche Médicale, Unité 631, {ddagger} Centre National de la Recherche Scientifique, Unité Mixte de Recherche 6102, Marseille, France; and § Institut National de la Santé et de la Recherche Médicale Unité 563, Université Toulouse III Paul Sabatier, and || Centre Hospitalier de l’Université Purpan, Service d’Anatomie Pathologique, Toulouse, France

Mutant mice in which tyrosine 136 of linker for activation of T cells (LAT) was replaced with a phenylalanine (LatY136F mice) develop a lymphoproliferative disorder involving polyclonal CD4 effector T cells that produce massive amounts of IL-4 and trigger severe Th2 inflammation. Naive CD4 T cells can themselves produce IL-4 and thereby initiate a self-reinforcing positive regulatory loop that involves the STAT6 transcription factor and leads to Th2 polarization. We determined the functional outcome that results when LatY136F T cells differentiate in the absence of such STAT6-dependent regulatory loop. The lack of STAT6 had no effect on the timing and magnitude of the lymphoproliferative disorder. However, in LatY136F mice deprived of STAT6, the expanding CD4 T cell population was dominated by Th1 effector cells that triggered B cell proliferation, elevated IgG2a and IgG2b levels as well as the production of autoantibodies. In contrast to LatY136F mice that showed no CD8 T cell expansion, the CD8 T cells present in LatY136F mice deprived of STAT6 massively expanded and acquired effector potential. Therefore, the lack of STAT6 is sufficient to convert the Th2 lymphoproliferative disorder that characterizes LatY136F mice into a lymphoproliferative disorder that is dominated by Th1 and CD8 effector T cells. The possibility to dispose of a pair of mice that differs by a single gene and develops in the absence of deliberate immunization large numbers of Th cells with almost reciprocal polarization should facilitate the identification of genes involved in the control of normal and pathological Th cell differentiation.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, European Commision (MUGEN network of excellence (Grant LSHG-CT-2005-005203) and SYBILLA programme (Grant HEALTH-F4-2008-201106)), Fondation pour la Recherche Médicale, (Défis de la Recherche en Allergologie), and Project DC in vivo from Agence Nationale pour la Recherche. C.A. is supported by a Postdoctoral Fellowship from La Fondation pour la Recherche Médicale. M. Mingueneau is supported by a Doctoral Fellowship from Ecole Normale Supérieure.

2 Address correspondence and reprint requests to Dr. Bernard Malissen, Centre d’Immunologie de Marseille-Luminy, Campus de Luminy, Case 906, 13288 Marseille, Cedex 09, France. E-mail address: bernardm{at}ciml.univ-mrs.fr

3 Abbreviations used in this paper: LAT, linker for activation of T cell; WT, wild type.




This article has been cited by other articles:


Home page
Sci SignalHome page
M. L. Dustin
Visualizing Immune System Complexity
Sci. Signal., April 14, 2009; 2(66): mr4 - mr4.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.